|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12th Street SW |
Address2 | |
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lucia DiVenere, Senior Director of Government Affairs |
Date | 10/19/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control (CDC); Agency for Healthcare Research and Quality (AHRQ); Comprehensive Sexuality Education funding (general); International family planning; Violence Against Women Programs; Indian Health Services.
Budget Control Act; FY13 Appropriations, Labor, HHS, Defense; Maternal Mortality Reviews; Electronic Birth and Death Records (CDC); National Fetal Infant Mortality Review (HRSA); Obesity Research, Treatment Prevention (HHS); Department of Defense (DOD) Ovarian Cancer Research Program; Health Disparities (HHS); Safe Motherhood (CDC); Preterm Research (NIH); Title V Block Grant (HRSA); STD Prevention (CDC); Title X, Family Planning; Reproductive Health; Prevention Public Health Fund; Birth Defects; National Children's Study; Medicaid and Medicare funding; H.R. 5652, Sequester Replacement Reconciliation Act of 2012; H.R. 5872, Sequester Transparency Act; H.R. 4310, National Defense Authorization Act for Fiscal Year 2013; H.R. 6091, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2013.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), U.S. SENATE, Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachell |
Gandell |
|
|
|
Anna |
Hyde |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
National HIV/AIDS Strategy (general); Emergency Contraception (general); H.R. 2679/S. 1440, PREEMIE.
H.R. 2954, Health Equity Accountability Act; HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding(general); Medical Liability Reform (general); Health IT (general); H.R. 2029/ S.1131, Birth Defects Prevention, Risk Reduction and Awareness Act; Prematurity(general); Obesity (general); Disparities (general); Prevention & Public Health Trust Fund(general); The Meaningful End to Defensive Medicine and Aimless Lawsuits; H.R. 2127, Newborn Act; H.R. 5/ S.1099, HEALTH Act; H.R. 452, Medicare Decisions Accountability Act of 2011; S.668, Health Care Bureaucrats Elimination Act; H.R.666, Birth Certificate Enhancement Act of 2011; H.R. 894, Maternal Health Accountability Act; Imaging (general); H.R. 2194/ S.1221, GEDI Act; H.R. 1676, Tanning Bed Cancer Control Act; National Prevention Strategy (general); H.R. 1216, To Amend Funding for Graduate Medical Education in Teaching Health Centers from Direct to Authorizing Appropriations; H.R. 2085/ S. 1214; Essential Health Benefits (general); Graduate Medical Education (general); H.R. 3418/ S. 1862, Stillbirth & SUID Prevention, Education & Awareness Act; Quality Improvement Measurement (general); H.R. 3620/ S. 1969, Quality Care for Moms and Babies Act; H.R. 3522 Family Act; Contraception (general); Preeclampsia (general); Antibiotics (general); H.R. 3586, Good Samaritan Health Professionals Act, NICHD Reorganization (general); CMS Provider Penalties (general); National Health Services Corps (general); Abortion (general); H.R. 3803, District of Columbia Pain-Capable Unborn Child Protection Act; H.R. 3541, Prenatal Nondiscrimination Act of 2012; H.R. 2299, Child Interstate Abortion Notification Act; S. 2262, Advancing FASD Research, Prevention, and Services Act; CMS Health IT incentive program, meaningful use Stage 2; H.R. 2104/S. 3338, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011; H.R. 5647, Pregnant Workers Fairness Act; H.R. 4628, Interest Rate Reduction Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachel |
Gandell |
|
|
|
Anna |
Hyde |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Sustainable Growth Rate Formula Reform (general); H.R. 452, Medicare Decisions Accountability Act; S. 688, Health Care Bureaucrats Elimination Act; Imaging (general); Medicaid (general); H.R. 2020/ S.1096, Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act; Strong Start Initiative; Primary care payment bonuses; H.R. 5707, Medicare Physician Payment Innovation Act of 2012.
H.R. 6352, Resident Physician Shortage Reduction and Graduate Medical Education Accountability and Transparency Act; H.R. 3667, Primary Care Workforce Access Improvement Act of 2011; H.R. 3269/S. 2347, Diagnostic Imaging Services Access Protection Act of 2011.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachel |
Gandell |
|
|
|
Anna |
Hyde |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |